ScionxBio is launched from Eleven Therapeutics, appoints Dr. Adi Gilboa-Geffen as CEO
Following a strategic horizontal split, ScionxBio focuses its xRNA modality on long-acting cardio-metabolic therapeutics under CEO Dr. Adi Gilboa-Geffen. BOSTON, MA, UNITED STATES, July 2, 2026 /EINPresswire.com/ -- ScionxBio, a preclinical- …